JP2007529539A5 - - Google Patents

Download PDF

Info

Publication number
JP2007529539A5
JP2007529539A5 JP2007504041A JP2007504041A JP2007529539A5 JP 2007529539 A5 JP2007529539 A5 JP 2007529539A5 JP 2007504041 A JP2007504041 A JP 2007504041A JP 2007504041 A JP2007504041 A JP 2007504041A JP 2007529539 A5 JP2007529539 A5 JP 2007529539A5
Authority
JP
Japan
Prior art keywords
complex
poly
group
hydrogel
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007504041A
Other languages
English (en)
Japanese (ja)
Other versions
JP4805911B2 (ja
JP2007529539A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/008632 external-priority patent/WO2005089805A2/en
Publication of JP2007529539A publication Critical patent/JP2007529539A/ja
Publication of JP2007529539A5 publication Critical patent/JP2007529539A5/ja
Application granted granted Critical
Publication of JP4805911B2 publication Critical patent/JP4805911B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007504041A 2004-03-15 2005-03-15 Hiv侵入阻害剤のポリマー系組成物及び複合体 Expired - Fee Related JP4805911B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55314604P 2004-03-15 2004-03-15
US60/553,146 2004-03-15
PCT/US2005/008632 WO2005089805A2 (en) 2004-03-15 2005-03-15 Polymer-based compositions and conjugates of hiv entry inhibitors

Publications (3)

Publication Number Publication Date
JP2007529539A JP2007529539A (ja) 2007-10-25
JP2007529539A5 true JP2007529539A5 (https=) 2008-03-27
JP4805911B2 JP4805911B2 (ja) 2011-11-02

Family

ID=34994420

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007504041A Expired - Fee Related JP4805911B2 (ja) 2004-03-15 2005-03-15 Hiv侵入阻害剤のポリマー系組成物及び複合体

Country Status (9)

Country Link
US (1) US9446139B2 (https=)
EP (1) EP1725262B1 (https=)
JP (1) JP4805911B2 (https=)
KR (1) KR101276422B1 (https=)
CN (1) CN101132812A (https=)
AU (1) AU2005222641B2 (https=)
CA (1) CA2558583C (https=)
MX (1) MXPA06010505A (https=)
WO (1) WO2005089805A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05007151A (es) * 2002-12-31 2005-09-21 Nektar Therapeutics Al Corp Polimeros terminados en maleimida hidroliticamente estables.
US7432331B2 (en) * 2002-12-31 2008-10-07 Nektar Therapeutics Al, Corporation Hydrolytically stable maleimide-terminated polymers
AU2004313242A1 (en) * 2004-01-07 2005-07-28 Trimeris, Inc. HIV gp41 HR2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus
DE102004031258A1 (de) * 2004-06-29 2006-02-09 Jennissen, Herbert P., Prof. Dr. Proteinhybride mit polyhydroxyaromatischen Aminosäure-Epitopen
WO2006110776A2 (en) 2005-04-12 2006-10-19 Nektar Therapeutics Al, Corporation Polyethylene glycol cojugates of antimicrobial agents
TWI341844B (en) 2006-02-02 2011-05-11 Trimeris Inc Hiv fusion inhibitor peptides with improved biological properties
US7462627B2 (en) * 2006-02-09 2008-12-09 Enzon Pharmaceuticals, Inc. Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
US7671067B2 (en) * 2006-02-09 2010-03-02 Enzon Pharmaceuticals, Inc. Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin
US8309680B2 (en) 2006-02-21 2012-11-13 Nektar Therapeutics Segmented degradable polymers and conjugates made therefrom
EP2089052A4 (en) * 2006-05-24 2011-02-16 Peg Biosciences POLYETHYLENE GLYCOL-BASED LINK COMPOUNDS AND BIOLOGICALLY ACTIVE CONJUGATES BASED ON SAID COMPOUNDS
PL2054074T3 (pl) 2006-08-04 2015-03-31 Prolong Pharmaceuticals Llc Zmodyfikowana erytropoetyna
KR20090108082A (ko) * 2007-02-09 2009-10-14 엔존 파마슈티컬즈, 인코포레이티드 7-에틸-10-하이드록시캄토테신 다분지형 고분자 접합체를 이용한 내성 또는 불응성 암의 치료방법
EP2134181A4 (en) * 2007-02-28 2011-09-28 Serina Therapeutics Inc ACTIVATED POLYOXAZOLINES AND COMPOSITION COMPRISING THE SAME
US20140011964A1 (en) 2007-02-28 2014-01-09 Serina Therapeutics, Inc. Activated Polyoxazolines and Conjugates and Compositions Comprising the Same
CA2682848A1 (en) * 2007-04-03 2008-10-16 Trimeris, Inc. Novel formulations for delivery of antiviral peptide therapeutics
CN101874038A (zh) * 2007-09-25 2010-10-27 特里梅里斯公司 治疗性抗-hiv肽的合成方法
TW201010732A (en) * 2008-08-29 2010-03-16 Enzon Pharmaceuticals Inc Method of treating RAS associated cancer
KR20110075029A (ko) * 2008-10-21 2011-07-05 엔즌 파마슈티칼스, 인코포레이티드 7-에틸-10-하이드록시캄토테신의 다중-암 고분자 컨쥬게이트로 신경모세포종의 치료
PT2501413T (pt) * 2009-11-18 2019-07-10 Nektar Therapeutics Formas de sal de ácido de conjugados de polímero-fármaco
WO2011084458A2 (en) * 2009-12-15 2011-07-14 The Johns Hopkins University Polymer-based compositions and methods for treatment of peritoneal disorders
US20110293686A1 (en) * 2010-05-28 2011-12-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-viral compositions and methods for administration
US20150072438A1 (en) * 2012-04-18 2015-03-12 Siemens Healthcare Diagnostic Inc. Compounds and methods for preparation of conjugate reagents
CN104109240A (zh) * 2014-07-13 2014-10-22 成都市绿科华通科技有限公司 一种可作为药物载体的多孔聚乙二醇的制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3670276B2 (ja) 1991-02-08 2005-07-13 プロゲニクス・ファーマスーティカルズ、インコーポレイテッド CD4― ガンマ・2キメラ及びCD4 ― IgG2・キメラ
US5446090A (en) * 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
US5932462A (en) * 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5792462A (en) * 1995-05-23 1998-08-11 University Of North Carolina At Chapel Hill Alphavirus RNA replicon systems
JP4078032B2 (ja) * 1998-03-12 2008-04-23 ネクター セラピューティックス エイエル,コーポレイション 近位の反応性基を持つポリ(エチレングリコール)誘導体
US6656906B1 (en) * 1998-05-20 2003-12-02 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
US20040228869A1 (en) 1998-12-16 2004-11-18 Progenics Pharmaceuticals, Inc. Synergistic inhibition of HIV-1 fusion and attachment, compositions and antibodies thereto
US6469136B1 (en) 1999-07-07 2002-10-22 Trimeris, Inc. Methods and composition for peptide synthesis
US6541020B1 (en) 1999-07-09 2003-04-01 Trimeris, Inc. Methods and compositions for administration of therapeutic reagents
US6413507B1 (en) * 1999-12-23 2002-07-02 Shearwater Corporation Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
US6602498B2 (en) * 2000-02-22 2003-08-05 Shearwater Corporation N-maleimidyl polymer derivatives
AU2001247254A1 (en) 2000-02-29 2001-09-12 Aaron Diamond Aids Research Centre Sulfated CCR5 peptides for HIV -1 infection
MXPA05000796A (es) 2002-07-24 2005-04-19 Hoffmann La Roche Aditivos de acidos polialquilenglicolicos.
HRP20050024A2 (en) 2002-07-24 2006-02-28 F. Hoffmann - La Roche Ag Pegylated t20 polypeptide
WO2004013165A1 (en) 2002-07-24 2004-02-12 F. Hoffmann-La Roche Ag Pegylated t1249 polypeptide
KR20050093856A (ko) * 2002-09-09 2005-09-23 넥타르 테라퓨틱스 에이엘, 코포레이션 수용성 중합체 알카날
US7556813B2 (en) 2002-09-27 2009-07-07 Trimeris, Inc. Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides
DE60331860D1 (en) * 2002-12-30 2010-05-06 Nektar Therapeutics Mehrarmige polypeptid-poly(ethylenglykol)-blockcopolymere als arzneistoffzufuhrvehikel
DE60322111D1 (de) * 2002-12-31 2008-08-21 Nektar Therapeutics Al Co Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen
JP4490369B2 (ja) * 2002-12-31 2010-06-23 ネクター セラピューティクス アラバマ,コーポレイション マレアミド酸ポリマー誘導体及びこれらの生物学的複合体
KR101207247B1 (ko) 2003-01-06 2012-12-03 넥타르 테라퓨틱스 티올-선택성 수용성 중합체 유도체
BRPI0407882B1 (pt) * 2003-02-26 2021-07-27 Nektar Therapeutics Composição compreendendo conjugados de polímero-porção de fator viii e seu método de fabricação
EP2644206B1 (en) * 2003-05-23 2019-04-03 Nektar Therapeutics PEG derivatives containing two PEG chains
CA2556032A1 (en) * 2004-03-15 2005-09-29 Trimeris, Inc. Site-specific chemical modification of hiv gp41-derived peptides

Similar Documents

Publication Publication Date Title
JP2007529539A5 (https=)
US8951989B2 (en) Hydrogel tissue adhesive having reduced degradation time
Dai et al. Recent development of functional aliphatic polycarbonates for the construction of amphiphilic polymers
JP5123939B2 (ja) 弾性が改良された組織接着剤
JP2009519961A5 (https=)
US8680200B2 (en) Polyglycerol aldehydes
JP2013500726A5 (https=)
Hans et al. Ring-opening polymerization of ε-caprolactone by means of mono-and multifunctional initiators: Comparison of chemical and enzymatic catalysis
JP2022500035A5 (https=)
JP2006519238A5 (https=)
WO2010111594A1 (en) Tissue adhesive and sealant comprising polyglycerol aldehyde
JP2017511322A5 (https=)
WO2010005740A3 (en) Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles
JP2005520006A5 (https=)
JP2012526548A5 (https=)
CN102181060A (zh) 聚乙烯醇-聚肽-聚乙二醇接枝共聚物及其制备方法
JP2005538224A (ja) 水溶性ポリマーアルカナール
JP2011080089A5 (https=)
WO2011112482A3 (en) Polymeric drug delivery conjugates and methods of making and using thereof
WO2011002888A2 (en) Hydrogel tissue adhesive for medical use
Li et al. Synthesis of linear polyether polyol derivatives as new materials for bioconjugation
CN111317852B (zh) 一种壳聚糖和聚碳酸亚丙酯复合的医用敷料及制备方法
KR20190142569A (ko) 폴리락틱산 강인화제용 조성물, 이를 통해 제조된 강인화성 폴리락틱산 공중합체 및 이의 제조방법
CN1613890A (zh) 一种生物可降解性聚酯接枝聚磷腈共聚物及其制备方法
CN114269812A (zh) 基于可交联亲水聚合物的医用组合物